Keywords: sb, postpones, trial, arthritis, antibody, smithkline, beecham

SB postpones trial of arthritis antibody

Article | 24 December 1998

Print This

SmithKline Beecham has decided to postpone its planned Phase IIb trialsof clenoliximab (also known as SB-217969 and IDEC-151), an antibody ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in